Abstract:Abstract The Genomic Landscape of Chinese Breast CancerBackground : The comprehensive genomic profiling (CGP) through next-generation sequencing (NGS) brought a new understanding of breast cancer and provided more information about further clinical treatment. However, the genomic features in Chinese breast cancer group are limited to date, which might offer both prognostic and predictive values. Patients and Methods: Hybrid capture-based CGP was performed on 126 primary and 38 relapsed/metastatic breast cancer patients using a 324-gene panel assay (FoundationOne CDx) to identify all classes of genomic alterations, including base substitutions, insertions and deletions, rearrangement and copy number changes. Tissue samples were obtained by surgery or biopsy. Results:There was no sample with unstable microsatellite status both in primary and relapsed/metastatic breast cancer patients. The tumor mutational burden was higher in Relapsed/metastatic breast cancer than in primary breast cancer (2.91±0.29 for primary, 5.10±0.50 for relapsed/metastatic breast cancer, respectively, p<0.001). There were 11 genes detected more than 10% incidence across all samples, including TP53(63.69%), PIK3CA(38.85%), ERBB2(22.29%), RAD21(17.20%), CCND1(15.29%), FGF3(14.01%), FGF19(14.01%), MYC(13.38%), NSD3(WHSC1L1)(11.36%), ZNF703(10.83%), among which RAD21, NSD3(WHSC1L1) were novel significantly mutated genes in Chinese breast cancer patients other than the previous genes identified in other ethnic groups and might be related to poor prognosis. The 10 top genes with greater difference mutational incidence between primary and relapsed/metastatic breast cancer were mostly identified in relapsed/metastatic group frequently (TP53, MYC, RAD21, PTEN, MLL2, CCND1, RB1), only 3 gene occurred more often in primary group (PIK3CA, FGFR1, MDM2). Relapsed/metastatic breast cancer patients were probably to get instruction in targeted therapies than primary group from CGP, the proportion of relapsed/metastatic breast cancer patients getting instruction in one or more targeted therapies was 94.74%, whereas the proportion of primary group was 76.98%(p=0.014). Conclusions:There was significant molecular heterogeneity between primary and relapsed/metastatic breast cancer in Chinese patients and between Chinese and other ethic group. Fig The mutational landscape of top 21 most frequently mutated genes (mutational incidence >5%) in Chinese breast cancers (n=184). The upper histogram showed the total number of mutations in every patient. The bottom bars indicated the clinical characteristics, samples were grouped by primary breast cancers (n=141) and relapsed/metastatic breast cancers (n=43). Sidebar on the left summarized the mutational incidence of each gene and listed the separate frequencies of primary and R/M patients. Sidebar on the right classified different mutation types. Citation Format: Qiuting You, Jianli Zhao, Kai Chen, Yi Chen, Minhua Zeng, Biaolin Wen, Linxiaoxiao Ding, Fengxi Su. The genomic landscape of Chinese breast cancer [abstract]. In: Proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium; 2020 Dec 8-11; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2021;81(4 Suppl):Abstract nr PS18-40.

Mutational Landscape of Head and Neck Cancer and Cervical Cancer in Chinese and Western Population.

Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China

Comprehensive Genomic Profiling in Chinese Patients with Clear Cell Renal Cell Carcinoma.

Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations

Characterization of the Genomic Landscape in Cervical Cancer by Next Generation Sequencing

Whole genome sequencing in high-grade cervical intraepithelial neoplasia patients from different ethnic groups in China

The genomic landscape of Chinese patients with upper tract urothelial carcinoma.

Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer

Different gene alterations in patients with non-small-cell lung cancer between the eastern and southern China

Prospective Clinical Sequencing of 1016 Chinese Prostate Cancer Patients: Uncovering Genomic Characterization and Race Disparity.

Clinical and Genomic Features of Chinese Lung Cancer Patients with Germline Mutations

Genomic Alterations in Head and Neck Squamous Cell Carcinoma Determined by Cancer Gene-Targeted Sequencing.

Integrated analysis of virus and host transcriptomes in cervical cancer in Asian and Western populations

The Genomic Profiling in Chinese Head and Neck Cancer and Incidence of NTRK Fusion

Comprehensive Genomic Analysis of Salivary Gland Carcinomas in a Chinese Population

Clinicopathologic characteristics of HPV-associated head and neck squamous cell carcinoma in Southern China: long-term retrospective study of 400 cases

Landscape of somatic alterations in large-scale solid tumors from an Asian population

Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts

Abstract PS18-40: the Genomic Landscape of Chinese Breast Cancer

879P Whole-genome Landscape of Head and Neck Melanomas in East Asia (China)

Precision Oncology of Lung Cancer: Genetic and Genomic Differences in Chinese Population